HK1029272A1 - 用噻唑烷二酮和磺酰脲治療糖尿病 - Google Patents
用噻唑烷二酮和磺酰脲治療糖尿病 Download PDFInfo
- Publication number
- HK1029272A1 HK1029272A1 HK00106765A HK00106765A HK1029272A1 HK 1029272 A1 HK1029272 A1 HK 1029272A1 HK 00106765 A HK00106765 A HK 00106765A HK 00106765 A HK00106765 A HK 00106765A HK 1029272 A1 HK1029272 A1 HK 1029272A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- pharmaceutically acceptable
- methyl
- dione
- ethoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715306A GB9715306D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
GB9715306.8 | 1997-07-18 | ||
PCT/GB1998/002109 WO1999003476A1 (en) | 1997-07-18 | 1998-07-16 | Treatment of diabetes with thiazolidinedione and sulphonylurea |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1029272A1 true HK1029272A1 (zh) | 2001-03-30 |
HK1029272B HK1029272B (zh) | 2007-12-07 |
Family
ID=
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2296653C (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
AP1287A (en) | Treatment of diabetes with rosiglitazone and insulin. | |
EP0998291B2 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
EP0999845B1 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
WO1999003478A1 (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor | |
US20020028768A1 (en) | Treatment of diabetes with rosiglitazone and insulin | |
US20020045649A1 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
HK1029272B (zh) | 用噻唑烷二酮和磺酰脲治疗糖尿病 | |
AU783539B2 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
US20030092750A1 (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor | |
HK1028200B (zh) | 用噻唑烷二酮和磺酰眼脲治疗糖尿病的方法 | |
HK1028550B (zh) | 用噻唑烷二酮、胰岛素促分泌素和双胍治疗糖尿病的方法 | |
HK1091393A (zh) | 用噻唑烷二酮和磺脲治疗糖尿病 | |
NZ518076A (en) | 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (BRL49653) for treating non-insulin dependent diabetes (NIDDM) | |
AU1552102A (en) | Treatment of diabetes with rosiglitazone and insulin | |
HK1028193A1 (zh) | 用噻唑烷二酮和偏甲酸精治療糖尿病 | |
HK1028193B (zh) | 用噻唑烷二酮和偏甲酸精治疗糖尿病 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE | Patent expired |
Effective date: 20180715 |